Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)

NCT03330002 is registered in ClinicalTrials.gov with Essential Medical, Inc. as lead sponsor.

NCT NCT03330002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03330002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
Lead sponsor
Essential Medical, Inc.
Phase
Observational
Overall status
Completed
Start date
February 23, 2018
Completion date
February 1, 2021
Enrollment
500 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

femoral arteriotomy closure